Table 1.

Case reports of primary intrapericardial SFTs reported in the literature supplemented with our case report

	Authors	Year	Age	Sex	Symptoms	Origin	Tumour imaging	Malignancy	Follow-up length (imaging modality)	Immuno-histochemical marker
1	Bortolotti U et al. [6]	1992	60	M	fatigue, chest discomfort, dyspnoea	AAo, PT	X-ray, echo, CT	Benign	9 m (X-ray, echo)	vimentin+
2	Seqawa D et al. [7]	1995	50	F	dyspnoea, palpitation	RV	X-ray, CT, MRI	NA	19 m (NA)	vimentin+
3	Flemming P et al. [8]	1996	53	F	NA	LV	NA	NA	died port HTX	CD34 + vimentin +
4	Andreani SM et al. [9]	1998	60	M	exertional dyspnoea	NA	X-ray, CT	Benign	4 y (NA)	NA
5	Corgnati G et al. [10]	2004	30	M	peripheral oedema	AAo, PT	X-ray, echo CT, MRI	Benign	18 m (NA)	NA
6	Bothe W et al. [11]	2005	39	F	palpitation	RA	echo	Benign	12 m (echo)	CD34 + vimentin +
7	Croti UA et al. [12]	2008	5 m	M	asymptomatic	LA	X-ray, echo	Benign	non-CV death after 6 m (NA)	CD34 +
8	Zhao XG et al. [13]	2012	55	M	chest distress, dyspnoea	RA	X-ray, CT	Malignant	died after surgery	CD34 +
9	Taguchi S et al. [14]	2013	49	F	asymptomatic	LV	CT, MRI	Malignant	NA	CD34 + vimentin + CD99 +
10	Bianchi G et al. [15]	2013	68	F	dyspnoea, fatigue	LV	echo, CT, MRI	Benign	12 m (echo)	CD34 + vimentin + Bcl2 +
11	Tamenishi A et al. [16]	2013	30	F	syncope	left PA	X-ray, CT	Benign	6y (NA)	CD34 +
12	Our case	2017	37	F	asymptomatic	PT	X-ray, echo, CT, MRI	Benign	3y (MRI)	CD34 + vimentin + CD99 + STAT6 +

M male, F female, NA no data available, AAo Ascending aorta, PT pulmonary trunk, RA right atrium, LA left atrium, LV left ventricle, PA pulmonary artery, m months, y years